GAIT II “Conflicts” With Existing Glucosamine/Chondroitin Data, CRN Says
This article was originally published in The Tan Sheet
Executive Summary
Results of a follow-up glucosamine and chondroitin study measuring loss of knee cartilage in patients with osteoarthritis are inconsistent with the trial's earlier arm
You may also be interested in...
GAIT Authors Seek Further Study Of Moderate-To-Severe Arthritis Sufferers
Authors of the GAIT study have submitted a proposal to further evaluate the effects of glucosamine and chondroitin on osteoarthritis patients by focusing specifically on those with moderate-to-severe pain, according to the study's lead researcher
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement